Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3843079 | Actas Urológicas Españolas | 2016 | 8 Pages |
Abstract
This is the first national European study to evaluate the therapeutic management of localised PC based on the risk group to which the patient belonged. Most young patients (â¤Â 65 years) with low-intermediate risk localised PC were treated with surgery, which adheres to the recommendations of the 2010 UAE guidelines. Various therapeutic combinations have been employed for patients with high-risk, locally advanced localised tumours, revealing the need for a multidisciplinary approach (Controlled-trials.com number: ISRCTN19893319).
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
B. Miñana, A. RodrÃguez-AntolÃn, F. Gómez-Veiga, C. Hernández, J.F. Suárez, J.M. Fernández-Gómez, M. Unda, J. Burgos, A. Alcaraz, P. RodrÃguez, C. Moreno, E. Pedrosa, J.M. Cózar,